DK3752253T3 - Sammensætning til forebyggelse og behandling af hårvækstforstyrrelser - Google Patents
Sammensætning til forebyggelse og behandling af hårvækstforstyrrelser Download PDFInfo
- Publication number
- DK3752253T3 DK3752253T3 DK19708402.3T DK19708402T DK3752253T3 DK 3752253 T3 DK3752253 T3 DK 3752253T3 DK 19708402 T DK19708402 T DK 19708402T DK 3752253 T3 DK3752253 T3 DK 3752253T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- composition
- hair growth
- growth disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT201800002630A IT201800002630A1 (it) | 2018-02-13 | 2018-02-13 | Composizione per la prevenzione e il trattamento dei disturbi della crescita dei capelli |
| PCT/EP2019/053591 WO2019158607A1 (en) | 2018-02-13 | 2019-02-13 | Composition for prevention and treatment of hair growth disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3752253T3 true DK3752253T3 (da) | 2023-09-04 |
Family
ID=62044904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19708402.3T DK3752253T3 (da) | 2018-02-13 | 2019-02-13 | Sammensætning til forebyggelse og behandling af hårvækstforstyrrelser |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US11793792B2 (da) |
| EP (1) | EP3752253B1 (da) |
| JP (1) | JP7356984B2 (da) |
| CN (1) | CN111818973B (da) |
| AU (1) | AU2019221535A1 (da) |
| CA (1) | CA3090401A1 (da) |
| DK (1) | DK3752253T3 (da) |
| EA (1) | EA202091933A1 (da) |
| ES (1) | ES2954733T3 (da) |
| FI (1) | FI3752253T3 (da) |
| HR (1) | HRP20231043T1 (da) |
| HU (1) | HUE062748T2 (da) |
| IL (1) | IL276669A (da) |
| IT (1) | IT201800002630A1 (da) |
| LT (1) | LT3752253T (da) |
| MA (1) | MA51831B1 (da) |
| MD (1) | MD3752253T2 (da) |
| MX (1) | MX2020008458A (da) |
| PL (1) | PL3752253T3 (da) |
| PT (1) | PT3752253T (da) |
| RS (1) | RS64581B1 (da) |
| SG (1) | SG11202007410TA (da) |
| SI (1) | SI3752253T1 (da) |
| WO (1) | WO2019158607A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110882173B (zh) * | 2019-12-05 | 2022-06-17 | 西北农林科技大学 | 一种靶向毛囊干细胞防治脱发的外用型日化品配方 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US7563813B2 (en) * | 2005-05-13 | 2009-07-21 | Wyeth | Iminothiazolidinone derivatives as SFRP-1 antagonists |
| FR2891543A1 (fr) * | 2005-10-05 | 2007-04-06 | Oreal | Composes phenyl-furyl-methyl-thiazolidine-2,4-diones ou phenyl-thienyl-methyl-thiazolidine-2,4-diones ; utilisations pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute ; compositions le contenant |
| US8859616B2 (en) * | 2011-01-21 | 2014-10-14 | Allergan, Inc. | Compounds and methods for enhancing hair growth |
| FR3020951B1 (fr) | 2014-05-16 | 2016-06-17 | Pierre Fabre Dermo-Cosmetique | Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique. |
-
2018
- 2018-02-13 IT IT201800002630A patent/IT201800002630A1/it unknown
-
2019
- 2019-02-13 PL PL19708402.3T patent/PL3752253T3/pl unknown
- 2019-02-13 SG SG11202007410TA patent/SG11202007410TA/en unknown
- 2019-02-13 HU HUE19708402A patent/HUE062748T2/hu unknown
- 2019-02-13 RS RS20230702A patent/RS64581B1/sr unknown
- 2019-02-13 MD MDE20201271T patent/MD3752253T2/ro unknown
- 2019-02-13 LT LTEPPCT/EP2019/053591T patent/LT3752253T/lt unknown
- 2019-02-13 AU AU2019221535A patent/AU2019221535A1/en active Pending
- 2019-02-13 EA EA202091933A patent/EA202091933A1/ru unknown
- 2019-02-13 WO PCT/EP2019/053591 patent/WO2019158607A1/en active Application Filing
- 2019-02-13 DK DK19708402.3T patent/DK3752253T3/da active
- 2019-02-13 HR HRP20231043TT patent/HRP20231043T1/hr unknown
- 2019-02-13 CA CA3090401A patent/CA3090401A1/en active Pending
- 2019-02-13 PT PT197084023T patent/PT3752253T/pt unknown
- 2019-02-13 MX MX2020008458A patent/MX2020008458A/es unknown
- 2019-02-13 JP JP2020539722A patent/JP7356984B2/ja active Active
- 2019-02-13 EP EP19708402.3A patent/EP3752253B1/en active Active
- 2019-02-13 MA MA51831A patent/MA51831B1/fr unknown
- 2019-02-13 SI SI201930616T patent/SI3752253T1/sl unknown
- 2019-02-13 CN CN201980011295.3A patent/CN111818973B/zh active Active
- 2019-02-13 US US16/969,246 patent/US11793792B2/en active Active
- 2019-02-13 ES ES19708402T patent/ES2954733T3/es active Active
- 2019-02-13 FI FIEP19708402.3T patent/FI3752253T3/fi active
-
2020
- 2020-08-12 IL IL276669A patent/IL276669A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL276669A (en) | 2020-09-30 |
| HRP20231043T1 (hr) | 2023-12-22 |
| MD3752253T2 (ro) | 2023-11-30 |
| SI3752253T1 (sl) | 2023-11-30 |
| MA51831B1 (fr) | 2023-09-27 |
| JP2021513509A (ja) | 2021-05-27 |
| MX2020008458A (es) | 2022-07-19 |
| BR112020016211A2 (pt) | 2020-12-08 |
| JP7356984B2 (ja) | 2023-10-05 |
| SG11202007410TA (en) | 2020-09-29 |
| EA202091933A1 (ru) | 2020-12-29 |
| CA3090401A1 (en) | 2019-08-22 |
| US11793792B2 (en) | 2023-10-24 |
| AU2019221535A1 (en) | 2020-10-01 |
| FI3752253T3 (fi) | 2023-09-01 |
| CN111818973A (zh) | 2020-10-23 |
| EP3752253B1 (en) | 2023-06-14 |
| EP3752253A1 (en) | 2020-12-23 |
| IT201800002630A1 (it) | 2019-08-13 |
| WO2019158607A1 (en) | 2019-08-22 |
| LT3752253T (lt) | 2023-10-10 |
| PT3752253T (pt) | 2023-09-04 |
| HUE062748T2 (hu) | 2023-12-28 |
| ES2954733T3 (es) | 2023-11-24 |
| CN111818973B (zh) | 2023-08-22 |
| PL3752253T3 (pl) | 2023-12-04 |
| MA51831A (fr) | 2020-12-23 |
| US20210000801A1 (en) | 2021-01-07 |
| RS64581B1 (sr) | 2023-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3673080T3 (da) | Antisense-oligomerer til behandling af lidelser og sygdomme | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3600270T3 (da) | Forbindelser og sammensætninger til behandling af hæmatologiske lidelser | |
| DK3570844T3 (da) | Azolopyrimidin til behandlingen af kræftrelaterede lidelser | |
| DK3445388T3 (da) | Materialer og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3858977T3 (da) | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf | |
| DK3866772T3 (da) | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-dien-1,4-dion til undertrykkelse og behandling af alpha-synucleinopathier, tauopathier og andre lidelser | |
| DK3532064T3 (da) | Kombinationsbehandlinger omfattende imidazopyrazinoner til behandlingen af psykiatriske og/eller kognitive lidelser | |
| DK3328864T3 (da) | Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser | |
| DK3790879T3 (da) | Triazolopyrimidinforbindelser og deres anvendelse til behandling af kræft | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| SG11202104053TA (en) | Compositions and methods for the treatment of estrogen-dependent disorders | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| DK3490584T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af melanom | |
| DK3861985T3 (da) | Sammensætninger og fremgangsmåder til behandling af øjensygdomme | |
| DK3897697T3 (da) | Peptider til behandling og forebyggelse af diabetes og forbundne lidelser | |
| DK3823617T3 (da) | Enantiomert oprenset gper-agonist til anvendelse ved behandling af sygdomstilstande og sygdomme | |
| DK3810128T3 (da) | Sammensætninger til behandling og/eller forebyggelse af proteinaggregeringssygdomme | |
| DK3752253T3 (da) | Sammensætning til forebyggelse og behandling af hårvækstforstyrrelser | |
| DK3630112T3 (da) | Kombination af regorafenib og nivolumab til behandling af cancer | |
| DK3615511T3 (da) | Lipopeptidforbindelser til behandling af smertelidelser | |
| DK3515409T3 (da) | Kompleks og sammensætninger til behandling af oftalmologiske og dermatologiske sygdomme | |
| DK3429616T3 (da) | Sammensætninger til behandlingen og forebyggelse af hov- og klovsygdomme | |
| DK3364975T3 (da) | Kombination af trazodon og gabapentin til behandling af smerter |